1. Home
  2. PMAX vs ANEB Comparison

PMAX vs ANEB Comparison

Compare PMAX & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • ANEB
  • Stock Information
  • Founded
  • PMAX 2019
  • ANEB 2020
  • Country
  • PMAX Hong Kong
  • ANEB United States
  • Employees
  • PMAX N/A
  • ANEB N/A
  • Industry
  • PMAX
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMAX
  • ANEB Health Care
  • Exchange
  • PMAX Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • PMAX 32.0M
  • ANEB 36.7M
  • IPO Year
  • PMAX 2024
  • ANEB 2021
  • Fundamental
  • Price
  • PMAX $0.42
  • ANEB $1.44
  • Analyst Decision
  • PMAX
  • ANEB Buy
  • Analyst Count
  • PMAX 0
  • ANEB 1
  • Target Price
  • PMAX N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • PMAX 4.4M
  • ANEB 12.2K
  • Earning Date
  • PMAX 02-21-2025
  • ANEB 02-21-2025
  • Dividend Yield
  • PMAX N/A
  • ANEB N/A
  • EPS Growth
  • PMAX N/A
  • ANEB N/A
  • EPS
  • PMAX 0.04
  • ANEB N/A
  • Revenue
  • PMAX $5,970,263.00
  • ANEB N/A
  • Revenue This Year
  • PMAX N/A
  • ANEB N/A
  • Revenue Next Year
  • PMAX N/A
  • ANEB N/A
  • P/E Ratio
  • PMAX $10.72
  • ANEB N/A
  • Revenue Growth
  • PMAX 30.05
  • ANEB N/A
  • 52 Week Low
  • PMAX $0.34
  • ANEB $0.80
  • 52 Week High
  • PMAX $4.70
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • ANEB 42.68
  • Support Level
  • PMAX N/A
  • ANEB $1.45
  • Resistance Level
  • PMAX N/A
  • ANEB $1.61
  • Average True Range (ATR)
  • PMAX 0.00
  • ANEB 0.13
  • MACD
  • PMAX 0.00
  • ANEB -0.02
  • Stochastic Oscillator
  • PMAX 0.00
  • ANEB 13.93

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: